Article
Targeting histone deacetylase in cardiac diseases
24 Jun 2024
Abstract excerpt
Histone deacetylases (HDAC) catalyze the removal of acetylation modifications on histones and non-histone proteins, which regulates gene expression and other cellular processes. HDAC inhibitors (HDACi), approved anti-cancer agents, emerge as a potential new therapy for heart diseases. Cardioprotective effects of HDACi are observed in many preclinical animal models of heart diseases. Genetic mouse models have been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
